Cholesterol drug fenofibrate may downgrade Covid-19 to common cold

Wednesday, July 29th, 2020

A study conducted by professor Yaakov Nahmias at Hebrew University in Israel has found that an existing cholesterol drug, fenofibrate, could ‘downgrade’ Covid-19 threat level to that of a common cold:

According to the research, the virus leads to deposits of lipids in the lungs. Nahmias partnered with Mount Sinai Medical Center researcher Dr Benjamin tenOever to gain better insights into SARS-CoV-2 mechanism of attack on the human body.

The researchers observed that the virus changes lipid metabolism in human lungs. They believe that halting this process could help prevent the onset of problems that increase the severity of the disease.

While SARS-CoV-2 hinders the ability of the body to break down fat, fenofibrate starts this process by binding and activating the DNA site that is blocked by the virus.

Comments

  1. Sam J. says:

    Ivermectin is another.

    https://www.webmd.com/lung/news/20200407/parasite-drug-shows-early-promise-against-covid-19

    Dr. Alam, who kindly did an interview with TrialSite News, reports that 98% of his COVID-19 patients are cured by the combined use of anti-parasitic drug ivermectin and antibiotic Doxycycline within 4 to 14 days.

    https://www.trialsitenews.com/bangladesh-medical-colleges-dr-tarek-alams-ivermectin-working-98-with-between-400-500-patients-more-research-to-come/

    https://www.trialsitenews.com/ivermectin-study-reveals-fantastic-results-100-of-60-patients-better-in-an-average-of-just-under-6-days/

    You can get this at Tractor supply for horses but they tell you not to use it.

Leave a Reply